- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01858805
Circulating Tumor Cells as a Biomarker for Preoperative Prognostic Staging in Patients With Esophageal Cancer
November 17, 2014 updated by: Dr. med. Matthias Reeh, Universitätsklinikum Hamburg-Eppendorf
Despite the availability of several preoperative diagnostic techniques, accurate pretreatment staging of esophageal cancer (EC) remains challenging.
Therefore, The investigators evaluated the prognostic significance of circulating tumor cells (CTCs) in patients with EC.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
123
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hamburg, Germany, 20246
- University Hospital Hamburg-Eppendorf
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
This prospective, single-institution study conducted at the University Hospital Hamburg-Eppendorf (Hamburg, Germany) enrolled 123 patients with ECs that were initially considered resectable.
Description
Inclusion Criteria:
- > 18 years
- resectable esophageal cancer
Exclusion Criteria:
- < 18 years
- esophageal cancer with preoperative distant metastases
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
detection of circulating tumors cells
This prospective, single-institution study conducted at the University Hospital Hamburg-Eppendorf (Hamburg, Germany) enrolled 123 patients with ECs that were initially considered resectable.
Only patients with histologically proven EC were included.
Peripheral blood samples for CTC analysis were collected immediately before surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
overall survival
Time Frame: 2 years
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
recurrence-free survival
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2010
Primary Completion (Actual)
April 1, 2014
Study Completion (Actual)
April 1, 2014
Study Registration Dates
First Submitted
May 14, 2013
First Submitted That Met QC Criteria
May 16, 2013
First Posted (Estimate)
May 21, 2013
Study Record Updates
Last Update Posted (Estimate)
November 18, 2014
Last Update Submitted That Met QC Criteria
November 17, 2014
Last Verified
November 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CTC-EC
- 184 (HAMBURGER STIFTUNG ZUR FÖRDERUNG DER KREBSBEKÄMPFUNG)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Resectable Esophageal Cancer
-
University of Wisconsin, MadisonActive, not recruitingResectable Esophageal Cancer | GastroEsophageal CancerUnited States
-
Asan Medical CenterRecruitingSubjects With Resectable and Localized Gastric Cancer | Subjects With Resectable Esophageal Cancer or Liver Cancer | Subjects With Resectable Liver CancerKorea, Republic of
-
P.O. WitteveenMerck KGaA, Darmstadt, GermanyTerminatedResectable Esophageal CancerNetherlands
-
Second Affiliated Hospital, School of Medicine,...Hangzhou Neoantigen Therapeutics Co., Ltd.RecruitingNeoantigen Vaccine in Esophagus Cancer Patients Following Neoadjuvant Therapy and Surgical ResectionResectable Esophageal CancerChina
-
Jianhua FuUnknownResectable Esophageal Cancer | Esophageal Squamous Cell Carcinoma by AJCC V8 StageChina
-
Per PfeifferCompletedFirst-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus orDenmark
-
PsiOxus Therapeutics LtdCompletedResectable Colon Cancer | Resectable Non-small Cell Lung Cancer | Resectable Bladder Cancer | Resectable Renal Cell CarcinomaSpain
-
Academisch Medisch Centrum - Universiteit van Amsterdam...Noordwest ZiekenhuisgroepActive, not recruitingOesophageal Adenocarcinoma | Esophageal Adenocarcinoma | Resectable CarcinomaNetherlands
-
Zhejiang Cancer HospitalUnknownEsophageal Squamous Cell Carcinoma ResectableChina
-
The First Affiliated Hospital of Zhengzhou UniversityNot yet recruitingResectable Esophageal Squamous Cell Carcinoma
Clinical Trials on esophagectomy
-
Sichuan UniversityUnknownPostoperative Complications | Esophageal Cancer | Pulmonary Function | DiaphragmChina
-
GEM Hospital & Research CenterUnknown
-
Fudan UniversityCompleted
-
University of California, IrvineWithdrawn
-
Austrian Society Of Surgical OncologyCompletedEsophageal Cancer
-
Fudan UniversityShanxi Province Cancer Hospital; The First Hospital of Jilin University; Fujian... and other collaboratorsUnknownEsophageal CancerChina
-
Shanghai Chest HospitalChanghai Hospital; The First Affiliated Hospital of Nanchang University; Shanghai... and other collaboratorsRecruitingEsophageal Cancer | Esophageal CarcinomaChina
-
Instituto do Cancer do Estado de São PauloRecruitingEsophagus Cancer | Carcinoma EsophagusBrazil
-
Fudan UniversityUnknownEsophageal Cancer | EsophagectomyChina
-
UMC UtrechtCompletedEsophageal Cancer | Esophageal CarcinomaNetherlands